Jakob Meineke1, Fabian Wenzel1, Iain D Wilkinson2, and Ulrich Katscher1
1Philips Research Europe, Hamburg, Germany, 2University of Sheffield
Synopsis
Quantitative
Susceptibility
Mapping (QSM) and
volumetry are
used to
study the deep gray-matter
nuclei of patients with Alzheimer’s Disease (AD) and healthy control subjects.
QSM is performed using “Joint background-field removal and
segmentation-Enhanced Dipole Inversion” (JEDI), which leverages the information
from automated model-based segmentation and allows the compact single-step
formulation of the ill-posed inversion problem of QSM. For
comparison QSM is also performed using L1-MEDI from the MEDI-Toolbox. The tissue
magnetic susceptibility shows no significant difference between the
Alzheimer group compared to
the
healthy control
group.
In contrast, the normalized volume of segmented gray-matter regions is significantly reduced
in AD patients.
Purpose
Disturbed
iron regulation and increased iron levels in specific brain regions have long
been associated with Alzheimer’s Disease (AD) (see, e.g., [1]). The
specific role of iron in the framework of AD, its causes and its consequences,
are, however, still widely unclear, particularly due to the lack of reliable in
vivo measurements.
In recent years, MR-based Quantitative Susceptibility Mapping (QSM)
has
become available to estimate in vivo iron
concentration in deep gray
matter quantitatively, assuming that magnetic susceptibility of deep gray
matter is predominantly determined by ferritin.Methods
21 patients
(age: 62±7 yrs)
with
AD and 32 healthy
controls (HC) (age: 68±11 yrs)
were
scanned on a 3T scanner (Ingenia,
Philips Healthcare, Best, The Netherlands) using a 32-channel head-coil after
obtaining informed consent from IRB. Data from one AD patient was excluded
due
to severe motion artifacts. The
scans are part of an ongoing prospective study within the framework of the EU
VPH-DARE@IT project and included a multi-echo gradient-echo sequence for QSM
(FOV: (AP, FH, RL) 240×145×210 mm3, acq
voxel 0.6×0.6×2.0 mm3, FA=14°, TE=3.5 ms,
ΔTE=4 ms, 7
echoes, TR=31 ms,
bipolar readout, BW=275.9 Hz/vx, SENSE (P/S) 1.8×1.2) and a T1-weighted
magnetization-prepared TFE sequence, used for model-based segmentation (FOV:
(AP, FH, RL) 240×240×170 mm3, acq
voxel 0.94×0.94×1.0 mm3, FA=8°, TR=8 ms, TFE
factor=222, inversion delay 1000 ms, BW=191.5 Hz/vx,
SENSE (P/S) 1.0×2.2). - To solve the ill-posed inverse problem of QSM, the
algorithm dubbed “Joint background-field removal and segmentation-Enhanced
Dipole Inversion” (JEDI) [2] was chosen, which uses a
priori
knowledge from automated anatomical segmentation within a single step
formulation of the inverse field-to-source problem. In previous studies, JEDI
demonstrated improved accuracy and less long-range modulations in numerical
simulations and in vivo volunteer data. Reconstruction
parameters were identical for all subjects. In addition to using
edge-information from the segmentation, edge-information from intermediate
iterations of the susceptibility was derived using Sobel filters and further
employed in the regularization term. Within the segmented regions, the mean of
the susceptibility was computed, referencing to the mean of the susceptibility
in the corpus callosum. For comparison, QSM reconstruction was performed using
L1-MEDI in combination with the Laplacian Boundary Value (LBV) method as
implemented in the MEDI toolbox with the default settings [3]. In
addition, the volume of the segmented regions normalized to total brain volume
was computed.
Results
Figure
1
exemplarily shows sagittal slices
of the susceptibility maps for an AD patient reconstructed using JEDI and
L1-MEDI, respectively. Figure 2 shows box-and-whisker
plots of the mean susceptibility
in
different segmented brain regions for the
AD and the HC groups,
reconstructed
using JEDI.
In none
of the segmented regions a statistically significant difference between groups
is observed, for both JEDI and L1-MEDI (i.e., AUC of ROC below 60% for all
cases). In contrast, as
shown in Figure 3,
a statistically
significant
difference
between
groups (AUC of ROC up to 75%) is observed
for the
normalized size of the segmented
brain regions (normalized size of all brain regions is lower in the AD group
than in the HC group except for the ventricles, where larger size is found for
the AD group, see Fig. 3).Discussion / Conclusion
Using
a fully automated approach for QSM reconstruction and region-specific
evaluation, which is compatible with a clinical setting, the tissue magnetic
susceptibility between a group of AD patients and a group of age-matched
controls has been studied. In contrast to expectations (see, e.g., [4]), no
significant difference has been found in the mean susceptibility between the AD
group and the HC group. This result is confirmed by using an independent
reconstruction program, using a different approach for background-field removal
and dipole inversion. The variability of mean susceptibility values within the
subject groups is unlikely to be caused by the QSM reconstruction, for example
due to excessive sensitivity to noise, and rather reflects substantial,
subject-specific biological variations. The reproducibility of the QSM
reconstruction method used here has been assessed by repeatedly scanning two
volunteers over several months, finding a standard deviation of the mean below
0.01 ppm for all brain regions. Working without a reference region does not
change these results. This excludes the possibility of disease-related changes
to the chosen reference tissue, the corpus callosum, potentially masking
changes to the studied regions.
The
volume changes of the brain regions
of the AD group
confirm numerous previous findings, and,
in this study, shows a higher discriminative power between AD and HC groups.Acknowledgements
This
project has received funding from European Union’s Seventh Framework Programme,
grant no. 601055.References
[1] Tao Y
et al., Perturbed
iron distribution in Alzheimer's disease serum,
cerebrospinal fluid, and selected brain regions: a
systematic review and
meta-analysis, Journal
of Alzheimer’s Disease: 42 (2014): 679–90
[2] Meineke
J et al., Quantitative
Susceptibility
Mapping Using
Segmentation-Enabled Dipole Inversion, ISMRM
25 (2015) 3321
[3]
MEDI toolbox, Cornell MRI Research Lab,
http://weill.cornell.edu/mri/pages/qsm.html
[4]
Acosta-Cabronero J et
al., In
Vivo Quantitative
Susceptibility Mapping
(QSM) in
Alzheimer’s Disease, PLoS ONE
8, (2013): e81093.